Last reviewed · How we verify
NCT04316429
The Impact of Consumption of Eggs in the Context of Plant-Based Diets on Endothelial Function, Diet Quality, and Cardio-Metabolic Risk Factors in Adults at Risk for Type 2 Diabetes
NA trial testing Egg included vegan phase in Type 2 Diabetes in 35 participants. Completed in 1 June 2021.
22 December 2020
Quick facts
| Lead sponsor | Griffin Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 35 |
| Start date | 9 June 2020 |
| Primary completion | 22 December 2020 |
| Estimated completion | 1 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Egg included vegan phase
- Vegan Phase
Conditions studied
- Type 2 Diabetes — all drugs for Type 2 Diabetes →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Griffin Hospital
Who can join
Adults 25 to 75, any sex, with Type 2 Diabetes or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Purpose To assess the impact of inclusion of 2 eggs daily for 6 weeks in an otherwise vegan diet compared to a vegan diet on cardio-metabolic risk and dietary pattern in adults at risk for type 2 diabetes. Hypotheses In comparison with a vegan diet, the inclusion of 2 eggs daily in an otherwise vegan diet will improve or have neutral effects on endothelial function and other markers of cardio-metabolic risk in adults at risk for type 2 diabetes. (2) In comparison with a vegan diet, the inclusion of 2 eggs daily in an otherwise vegan diet will improve diet quality and nutrient intake in adults at risk for type 2 diabetes. (2) In comparison with a vegan diet, the inclusion of 2 eggs daily in an otherwise vegan diet will improve diet quality and nutrient intake in adults at risk for type 2 diabetes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Egg Consumption in the Context of Plant-Based Diets and Cardiometabolic Risk Factors in Adults at Risk of Type 2 Diabetes.
Njike VY, Treu JA, Kela GCM, Ayettey RG, et al · · 2021 · cited 6× · PMID 34494112 · DOI 10.1093/jn/nxab283
Verify or expand the search:
- PubMed search for NCT04316429
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type 2 Diabetes
Currently open trials in the same condition.
- NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
- NCT07254689 — The Food for Health Study · NA · recruiting
- NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting
Other Griffin Hospital trials
Trials by the same sponsor.
- NCT05939349 — A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes a · NA · unknown
- NCT05628597 — Effects of Fos Biomedical Device on Diabetes Risk Factors and Sleep Quality in Adults at Risk for Type 2 Diabetes · NA · completed
- NCT05081271 — COVID-19 Booster Vaccination in Persons With Multiple Sclerosis · EARLY_PHASE1 · terminated
- NCT04096443 — Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis · EARLY_PHASE1 · active not recruiting
- NCT04025281 — Post-prandial Effects of Extra Virgin Olive Oil on Endothelial Function in Adults at Risk for Type 2 Diabetes · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04316429 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Griffin Hospital
- Last refreshed: 10 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04316429.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing